Blueprint Medicines (BPMC) PT Raised to $115 at Wedbush

October 30, 2020 5:30 AM EDT
Get Alerts BPMC Hot Sheet
Price: $86.63 +2.23%

Rating Summary:
    13 Buy, 6 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Blueprint Medicines (NASDAQ: BPMC) to $115.00 (from $102.00) while maintaining a Outperform rating.

You May Also Be Interested In

Related Categories

Analyst PT Change